AI-powered dermatology platform cure skin Raised $20 million in Series B funding round led by HealthQuad. JSW Ventures, Khosla Ventures, and Sharp Ventures also participated in the round.
„These funds will help us further strengthen our AI capabilities, accelerate growth, and expand our solution offering,“ co-founder and CEO Guna Kakrapati said in a statement. Stated.
Cure skin that I raised before $5 million in Series A funding. To date, it claims to have treated various skin conditions for around 1.5 million customers through its app. It points out that more than 80% of these people are from tier 2 and tier 3 cities.
Health tech startup focused on diabetes sugar fit has received $5 million in additional Series A funding from B Capital.
This makes the total Series A fundingthe first round was made in November and amounted to $16 million.
The company said in a statement that it will use the additional funding to expand its product offering, improve its presence and accelerate research and development in diabetes management.
Since its launch by the end of 2021, Sugar.fit currently serves over 30,000 users on its platform, offering a personalized and comprehensive program for diabetes management powered by continuous glucose monitoring technology and data. We offer We also recently started operating a diabetes clinic in Bangalore, offering a wide range of services including stress therapy, live fitness and yoga sessions, and VR chromotherapy.
diagnostic service provider cardio tracka brand of Uber Diagnostics, has raised $2 million in a pre-Series A funding round led by angel investor and principal at an international investment banking firm, Girish Narasimhan.
This is in addition to the $1.6 million previously raised from wealthy individuals. It has not disclosed where or how the new funds will be used.
Cardiotrack provides telemedicine kits, medical-grade IoT diagnostic devices, and data analytics solutions, serving some of India's largest health and life insurance companies and a network of over 300 diagnostic centers. I am.